High-Intensity Interval Training (HIIT) for Alzheimer's Disease
Also known as: HIIT, High-intensity exercise, Sprint interval training
Exercise is the most evidence-backed intervention for AD prevention, with HIIT providing superior neurotrophic and vascular benefits.
Mechanism of Action
HIIT maximally stimulates BDNF release (3-5x increase vs moderate exercise), activates PGC-1α for mitochondrial biogenesis, enhances cerebral blood flow and angiogenesis, promotes hippocampal neurogenesis via irisin, and improves insulin sensitivity and glucose metabolism.
General mechanism: High-intensity cardiovascular stress. BDNF/irisin release, PGC-1α activation, NK cell mobilization, insulin sensitization, angiogenesis.
Current Evidence
Meta-analyses show exercise reduces AD risk by 30-45%. HIIT shows superior cognitive improvement vs moderate-intensity exercise in older adults. The EXERT trial demonstrated exercise benefits in MCI.
Clinical Status: Strong epidemiological and clinical trial evidence. EXERT trial positive.
Safety Profile
Generally safe when appropriately prescribed. Cardiac screening recommended for sedentary individuals. Adapt to patient capacity. ALS: moderate intensity preferred.
Key Research Questions
- Is HIIT superior to moderate exercise for AD prevention?
- Can irisin-mediated hippocampal neurogenesis be therapeutic in AD?